The latest cancer drugs news
Browsing: Cancer Drug News
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers
A new drug designed to counter the effects of an important, but very hard to…
ICR calls for change to bring immunotherapies to more cancer patients
Major changes to the way immunotherapy drugs are researched and evaluated are essential if they…
Response to adjuvant bevacizumab among patients with resected melanoma may vary by age
Younger patients with resected melanoma had some benefit from adjuvant treatment with the anti-VEGF therapeutic…
One mouse at a time: new approach to testing potential drugs for children’s cancers
A team of researchers in the US and Australia have developed a way of testing…
ENA 2020: Existing heart drugs may help cancer patients respond better to PD(L)1 immunotherapy
Researchers have found that a class of commonly-used heart drugs may also improve patients’ responses…
Cholesterol medications linked to lower cancer-related deaths in women
Among women with breast cancer, colorectal cancer, or melanoma, those who were taking cholesterol-lowering medications,…
Efavirenz induces DNA damage response pathway in lung cancer
The cover for Issue 41 of Oncotarget features Figure 7, “IPA ATM-signaling pathway in (A) EFV treated MRC-5 and…
Statins may reduce cancer risk through mechanisms separate to cholesterol
Cholesterol-lowering drugs called statins may reduce cancer risk in humans through a pathway unrelated to…
New study sheds light on the best drug choices for some patients with advanced breast cancer
Patients with metastatic breast cancer carrying a particular mutation fare better on one form of…
Enhanced reimbursement to oncology clinics increases prescriptions of evidence-based drugs
A pay-for performance program that offers enhanced reimbursement to oncology practices for prescribing high-quality, evidence-based…